CONMED Corporation Common Stock (CNMD)
Stock · NYSE · Health Care
$46.72as of 10/16/2026
Price chart
Active signals
CNMD Signal Track Record
How signals performed across all stocks →What CNMD's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 29 | -2.4% | 34% | September 18, 2026 |
| Bollinger Band Breakdown | 27 | +1.3% | 52% | October 6, 2026 |
| Bollinger Band Breakout | 17 | -1.8% | 41% | August 4, 2026 |
| 200-Day Moving Average TouchActive now | 11 | -4.0% | 18% | January 21, 2025 |
| Any 20-session window (baseline) | -2.1% | 43% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About CNMD
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tiss…
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Employees
- 3,900
- Website
- www.conmed.com/
Fundamentals
- 1-day range
- $45.67$47.76
- Market cap
- $1.49B
- P/E (trailing)
- 25.13
- P/E (forward)
- 9.86
- EPS (trailing)
- $1.85
- Dividend yield
- 0.74%
- Beta
- 0.91
- Avg. volume
- 415.4K
- Ex-dividend date
- September 15, 2025
- Dividend pay date
- October 3, 2025
How CONMED Corporation Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 17, 2026 · via SEC EDGAR / Finnhub
Forecasts
6 analyst ratings
CONMED Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- CNMDCONMED Corporation Common Stock$46.72▼ 0.89%Market cap $1.49BP/E 25.13$31.44$53.66
- INMDInMode Ltd. Ordinary Shares$14.16▼ 1.12%Market cap $957.98MP/E 10.66$12.72$16.67
- CBLLCeriBell Inc. Common Stock$25.04▼ 9.41%Market cap $692.45MP/E —$10.85$26.63
- AXGNAxogen Inc. Common Stock$34.62▼ 2.83%Market cap $2.38BP/E —$15.27$52.91
- CVCapsoVision Inc. Common Stock$6.53▲ 1.24%Market cap $344.75MP/E —$4.46$15.37
- FOCLEDAP TMS S.A. American Depositary Shares$4.09▼ 0.97%Market cap $228.65MP/E —$3.99$6.4
- TMDXTransMedics Group Inc. Common Stock$70.78▼ 7.50%Market cap $2.78BP/E 17.33$60.11$156
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CNMD CONMED Corporation Common Stock | $1.49B | 25.13 | $46.72 | ▼ 0.89% | $31.44$53.66 |
| INMD InMode Ltd. Ordinary Shares | $957.98M | 10.66 | $14.16 | ▼ 1.12% | $12.72$16.67 |
| CBLL CeriBell Inc. Common Stock | $692.45M | — | $25.04 | ▼ 9.41% | $10.85$26.63 |
| AXGN Axogen Inc. Common Stock | $2.38B | — | $34.62 | ▼ 2.83% | $15.27$52.91 |
| CV CapsoVision Inc. Common Stock | $344.75M | — | $6.53 | ▲ 1.24% | $4.46$15.37 |
| FOCL EDAP TMS S.A. American Depositary Shares | $228.65M | — | $4.09 | ▼ 0.97% | $3.99$6.4 |
| TMDX TransMedics Group Inc. Common Stock | $2.78B | 17.33 | $70.78 | ▼ 7.50% | $60.11$156 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Harbor SMID Cap Value ETF Q2 2026 Contributors And DetractorsSeekingAlpha · 9/19/2026
- 1 Unpopular Stock That Should Get More Attention and 2 We Turn DownYahoo · 9/18/2026
- Here's Why You Should Retain CONMED Stock in Your Portfolio for NowYahoo · 9/16/2026
Insider Activity
Insider Actions →- John E. Gallagher · July 15, 2026 · Grant30.5K
- John E. Gallagher · July 15, 2026 · Grant26.9K
- John E. Gallagher · July 15, 2026 · Grant35.1K
- Martin Celine Christine · July 1, 2026 · Grant5.6K
- Mirviss Jeffrey B. · July 1, 2026 · Grant5.6K
- LaVerne H. Council · June 2, 2026 · Option Exercise668
- Schwarzentraub Barbara J · June 2, 2026 · Option Exercise668
- Mark Kaye · June 2, 2026 · Option Exercise668
- Farkas Charles · June 2, 2026 · Option Exercise668
- Bronson David M. · June 2, 2026 · Option Exercise668
- LaVerne H. Council · June 1, 2026 · Grant5.8K
- Schwarzentraub Barbara J · June 1, 2026 · Grant5.8K
- Mark Kaye · June 1, 2026 · Grant5.8K
- Kelderman Kim · June 1, 2026 · Grant5.8K
- Farkas Charles · June 1, 2026 · Grant5.8K
Institutional Ownership
March 31, 2026
- Total shares held
- 31.65M
- Total value held
- $1.10B
- Institutional holders
- 229
- Unknown4.83M
- Unknown2.57M
- Unknown1.64M
- Unknown1.40M
- Unknown1.39M
- Unknown1.38M
- Unknown1.38M
- Unknown1.00M
- Unknown987.8K
- Unknown934.6K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
No CNMD-Specific News in Past 7 Days
The only news article in the past week references Henry Schein (HSIC), not CONMED itself. This appears to be a sector comparison piece tracking HSIC's performance since its last earnings release. There is no recent CNMD-specific news to report. Market participants seeking updates on CONMED's operations, financial results, or strategic developments will need to look beyond this seven-day window.
No CNMD-Specific News in Past 7 Days. The only news article in the past week references Henry Schein (HSIC), not CONMED itself. This appears to be a sector comparison piece tracking HSIC's performance since its last earnings release. There is no recent CNMD-specific news to report. Market participants seeking updates on CONMED's operations, financial results, or strategic developments will need to look beyond this seven-day window.